AMPOULES AND SYRINGES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Ampoules and Syringes Market Size and Share Analysis- Growth Trends and Forecasts (2026-2033)

The Ampoules and Syringes Market size is anticipated to grow at a CAGR of 7.2% with USD 12 Bn in 2026 and is expected to reach USD 19.3 Bn in 2033. The primary drivers are defined by rising demand for injectable drug delivery systems, expansion of biologics and vaccine programs, increasing prevalence of chronic diseases, and growing adoption of prefilled syringes and safety-engineered devices. According to the World Health Organization, billions of injections are administered globally each year, highlighting critical demand for safe delivery systems. This is strengthening focus on sterile packaging, infection control, and clinical efficiency pathways.

Key Takeaways

• The syringes segment is likely to dominate the market with 68.4% in 2026. The segment’s growth is owing to the rising global demand for injectable biologics, insulin delivery, and vaccination programs, alongside increasing adoption of safety-engineered syringes in clinical settings. In the U.S., CDC projected up to 154 million flu vaccine doses for the 2025–2026 season, thereby showing high annual demand for vaccine-administration devices such as syringes and ampoules.
• The glass segment is set to lead with 69.2% in 2026. The segment’s growth is owing to the strong compatibility with high-value biologics, superior chemical stability, and preference in prefilled drug delivery systems used in chronic and specialty care.
• The hospitals & clinics segment is set to lead with 57.5% in 2026. The segment’s growth is owing to the high patient inflow for chronic disease management, vaccination delivery, and emergency care requiring sterile injectable administration under clinical supervision. According to the World Health Organization (WHO), more than 2.4 billion people globally require rehabilitation or long-term health services annually, strengthening hospital-based treatment pathways that rely heavily on syringes and ampoules.
• North America is expected to acquire the prominent share of 40.1% in 2026. The region’s growth is owing to the strong regulatory frameworks, high adoption of advanced drug delivery devices, and rapid expansion of biologics, vaccines, and specialty pharmaceuticals. According to the CDC, routine immunization programs in the U.S. alone administer millions of vaccine doses annually, supporting sustained demand for syringes and ampoules in public health infrastructure

Segmental Insights

Why is Syringes Segment Acquiring the Largest Share?

On the basis of product type, the syringes segment is projected to account for the largest Ampoules and Syringes Market share of 68.4% in 2026. The segment’s growth is owing to its essential role in drug administration, vaccination programs, and emergency medical procedures. Syringes are extensively used across hospitals, clinics, and homecare settings due to their affordability as well as ease of use.

In June 2026, Alkem Laboratories launched semaglutide in single-shot pre-filled syringes in India, starting at INR 350, becoming the first firm to offer such delivery format. The launch aims to improve affordability and access alongside existing pen formats for diabetes and obesity treatment.

Glass hold the Largest Market Share

On the basis of material, the glass segment lead with a major 69.2% share in 2026. The growth is owing to its superior chemical resistance, inert nature, and compatibility with sensitive injectable drugs. The FDA pharmaceutical packaging compliance guidelines highlight glass as the preferred material for sterile injectable drug storage.

In October 2025, SCHOTT Pharma launched a 5.5 ml prefillable glass syringe designed for large-volume biologic drug delivery and homecare use. The syringe is compatible with Ypsomed autoinjectors and supports the growing demand for self-administration of chronic as well as specialty injectable therapies.

Market Drivers

Rising Innovations in Sterile Injectable Packaging are Transforming the Ampoules and Syringes Market in India

India is emerging as a major hub for pharmaceutical manufacturing innovation, particularly in sterile injectable packaging systems like ampoules and syringes. The country’s strong generics industry, expanding biologics pipeline, and government-led initiatives such as Make in India are speeding up the domestic production of high-quality glass tubing, prefilled syringes, and sterile ampoules.

In August 2025, SCHOTT expanded its India operations by launching syringe and cartridge glass tubing production in Gujarat. The facility strengthens the supply for prefillable syringes and GLP-1 injectable therapies. This development is expected to strengthen the adoption of glass ampoules and syringe components in pharmaceutical manufacturers and contract packaging organizations in India.

Safety-Engineered Syringes and Prefilled Systems: A Major Breakthrough in the Market

Safety-engineered syringes and prefilled delivery systems are transforming injectable drug administration. The use of these systems assist in reducing contamination risks, improving dosing accuracy, and minimizing needlestick injuries.

The CDC injection safety guidelines emphasize single-use syringes and sterile practices to prevent infection transmission. The FDA also highlights risks associated with unsafe injection practices and supports the sterile single-use systems in clinical environments.

In March 2024, Becton Dickinson increased the syringe production in the United States after the FDA raised quality concerns over certain China-made syringes. The firm ramped up output at its Nebraska and Connecticut facilities to support the demand amid ongoing regulatory scrutiny and supply chain adjustments. Such innovations are expected to speed up the market growth during the forecast period.

Current Events and Their Impact

Ampoules and Syringes Market Trends

• Prefilled syringes are gaining traction owing to dosing accuracy and reduced contamination risk. The FDA approvals for biologics delivered via prefilled systems are increasing. This supports the demand in hospitals and homecare settings across the globe.
• Expansion of monoclonal antibodies and insulin therapies is increasing injectable drug usage, thereby strengthening the demand for sterile ampoules and syringes in pharmaceutical manufacturing.
• Manufacturers are adopting automated sterile production lines to improve efficiency and reduce contamination risks, thus enhancing the global supply chain scalability.
• Unsafe injection practices remain a major global concern driving the safety syringe adoption. The WHO reports that about 5% of injections in developing regions are still unsafe, thereby increasing risks of blood-borne disease transmission and speeding up the demand for auto-disable and safety-engineered syringes.
• Supportive healthcare reimbursement and expanded access to injectable therapies are also boosting the market penetration. In the U.S., Medicare Part B continues to cover medically necessary injectable treatments administered in outpatient and hospital settings. This ensures sustained demand for ampoules and syringes in therapeutic areas like oncology, diabetes, and autoimmune diseases.

Regional Insights

North America Dominates Owing to the Advanced Healthcare Infrastructure

The North America region accounts for 40.1% of the market share in 2026. The region’s growth is owing to the strong healthcare infrastructure, high pharmaceutical spending, and advanced biologics adoption. The U.S. is a major contributor, with extensive vaccine distribution programs and chronic disease treatment demand. According to the CDC (2024), over 240 million vaccine doses are administered annually in the U.S., driving syringe consumption.

In October 2025, West Pharmaceutical Services launched the West Synchrony Prefillable Syringe System, a fully verified platform designed for biologics and vaccines. The system integrates components and regulatory support from a single supplier to streamline drug delivery development and accelerate regulatory submissions.

Asia Pacific Ampoules and Syringes Market Trends

Asia Pacificis expected to witness strong growth in market over the forecast period. The region’s growth is owing to the rising immunization coverage, injectable biologics demand, and stricter injection safety enforcement across public health systems. According to the World Health Organization (WHO), unsafe injection practices contribute to an estimated 1.7 million hepatitis B infections annually worldwide, reinforcing government-led adoption of auto-disable and safety syringes in large immunization programs.

In June 2026, West Pharmaceutical Services launched the West Synchrony Prefillable Syringe System at CPHI Chin. This is strengthening integrated drug delivery solutions for biologics and vaccines in China’s expanding biopharmaceutical market.

Increasing Adoption of Prefilled Syringes are Accelerating the Ampoules and Syringes Market in United States

In the United States, the Ampoules and Syringes Market is influenced by increasing adoption of prefilled syringes for biologics and vaccines, reducing contamination risks. According to FDA data from 2026, the approval of new therapeutic proteins requiring precise parenteral administration is accelerating this sector. Notably, as of June 2026, the FDA approved Ranibizumab-hkdz, a key interchangeable biosimilar available in prefilled syringes.

In January 2026, Becton Dickinson announced a USD 110 million investment to expand U.S. production of prefillable syringes in Columbus, Nebraska. The expansion includes BD Neopak glass prefillable syringe manufacturing to support biologic and GLP-1 drug delivery and strengthen domestic pharmaceutical supply chains.

Japan Ampoules and Syringes Market Trends

Japan is expected to grow steadily due to high demand for prefillable, safety-engineered systems to manage an aging population. According to Nipro’s 73rd term IR materials (May 2026), solid sales of injection needles and vascular products in the domestic medical segment are strengthening.

In May 2026, Samsung Bioepis launched its ustekinumab biosimilar syringe in Japan under the NIPRO partnership following national insurance listing approval. The product expands access to treatments for autoimmune conditions such as plaque psoriasis and psoriatic arthritis in the Japanese market.

Who are the Major Companies in Ampoules and Syringes Industry

Some of the major key players in Ampoules and Syringes Market are Schott AG, Gerresheimer AG, Becton, Dickinson, and Company, West Pharmaceutical Services, Inc., Nipro Corporation, Vetter Pharma International GmbH, Stevanato Group, TOPAS Advanced Polymers, JSR CORPORATION., Baxter International Inc., Terumo Corporation, B. Braun Melsungen AG, Unilife Corporation, Ypsomed Holding AG, Medtronic, and Zeon Corporation

Key News

• In March 2026, Sun Pharmaceutical Industries launched semaglutide injections in India under the brands Noveltreat and Sematrinity for weight management and type 2 diabetes treatment. The products are offered in multiple dose strengths with prefilled and multi-dose pen formats to improve affordability and patient convenience.
• In March 2026, Dr. Reddy’s Laboratories launched Obeda, India’s first DCGI-approved generic semaglutide injection for type 2 diabetes and weight management, available in prefilled pens with 2 mg and 4 mg strengths, priced around INR 4,200 per month, following patent expiry and Phase III validation.
• In April 2025, Polymer Medical ramped up production of single-use plastic ampoules for James Alexander Corp, expanding its contract injection molding capabilities in the US. The development strengthens tooling transfer expertise and supports rising demand for high-quality medical and pharmaceutical disposable packaging solutions.

Market Report Scope

Ampoules and Syringes Market Report Coverage

Analyst Opinion

• The Ampoules and Syringes Market growth is primarily driven by the global reliance on injectable drug delivery. According to the World Health Organization (WHO), over 16 billion injections are administered annually worldwide, highlighting the critical role of syringes and ampoules in routine healthcare, vaccination programs, and emergency medicine rather than being a discretionary medical segment.
• Vaccination programs and public health initiatives remain a core demand driver. WHO and UNICEF-led immunization efforts continue to expand across developing economies, with billions of vaccine doses administered annually, requiring high volumes of sterile prefilled syringes and glass ampoules to ensure safety, dosage accuracy, and contamination-free drug delivery in large-scale immunization campaigns.
• The shift toward biologics, biosimilars, and specialty injectable therapies is accelerating adoption of high-precision primary packaging. Regulatory agencies such as the U.S. FDA increasingly emphasize sterility assurance, container closure integrity, and single-dose safety standards, which is pushing pharmaceutical manufacturers toward advanced auto-disable syringes and high-quality ampoule systems, strengthening long-term market expansion globally.

Market Segmentation

• By Product Type (Revenue, USD Bn, 2021-2033)
  • Syringes
  • Ampoules
• By Material (Revenue, USD Bn, 2021-2033)
  • Glass
  • Plastic
• By End User (Revenue, USD Bn, 2021-2033)
  • Hospitals & Clinics
  • Ambulatory Surgery Centers
  • Others
• Global Ampoules and Syringes Market, By Region (Revenue, USD Bn, 2021-2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • Central Africa
    • North Africa
• Key Players
  • Schott AG
  • Gerresheimer AG
  • Becton, Dickinson, and Company
  • West Pharmaceutical Services, Inc.
  • Nipro Corporation
  • Vetter Pharma International GmbH
  • Stevanato Group
  • TOPAS Advanced Polymers
  • JSR CORPORATION
  • Baxter International Inc.
  • Terumo Corporation
  • Braun Melsungen AG
  • Unilife Corporation
  • Ypsomed Holding AG
  • Medtronic
  • Zeon Corporation

Sources

Primary Research Interviews

• Pharmaceutical manufacturers (injectables & parenteral drugs)
• Vaccine production companies
• Hospital procurement managers
• Ambulatory surgical center (ASC) supply chain managers
• Pharmaceutical packaging manufacturers
• Medical device distributors (syringes, prefilled syringes, ampoules)
• Key opinion leaders (KOLs) in pharmaceutical delivery systems

Databases

• World Health Organization (WHO)
• Centers for Disease Control and Prevention (CDC)
• National Institutes of Health (NIH)
• Organisation for Economic Co-operation and Development (OECD)
• U.S. Food and Drug Administration (FDA) drug/device databases
• European Medicines Agency (EMA) databases

Magazines

• Pharmaceutical Technology
• Drug Development & Delivery
• Pharmaceutical Manufacturing
• Medical Device & Diagnostic Industry (MD+DI)
• Packaging Digest

Journals

• International Journal of Pharmaceutics
• Journal of Pharmaceutical Sciences
• PDA Journal of Pharmaceutical Science and Technology
• European Journal of Pharmaceutics and Biopharmaceutics
• AAPS PharmSciTech

Newspapers

• The New York Times
• The Guardian
• The Wall Street Journal
• Financial Times

Associations

• Parenteral Drug Association (PDA)
• International Society for Pharmaceutical Engineering (ISPE)
• U.S. Pharmacopeia (USP)
• European Federation of Pharmaceutical Industries and Associations (EFPIA)
• World Packaging Organisation (WPO)
• ISO Technical Committees (pharmaceutical packaging standards)

Public Domain Sources

• Company Annual Reports and Investor Presentations (syringe, ampoule, and packaging manufacturers)
• Government Health Ministry Publications (drug administration, vaccination programs)
• Clinical Trial Registries such as ClinicalTrials.gov and EU Clinical Trials Register
• WHO immunization and injectable drug safety reports
• National regulatory authority databases (FDA, EMA, CDSCO)

Proprietary Elements

• CMI Data Analytics Tool, Proprietary CMI Existing Repository of Information for Last 10 Years